메뉴 건너뛰기




Volumn 21, Issue 6, 2001, Pages 499-512

Tyrosine kinase inhibitors: From rational design to clinical trials

Author keywords

ATP competitive inhibitors; GlivecTM; Pharmacophore model; PKI166; PTK787; STI571; Tyrosine kinase inhibitors; ZK224584

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 [(4,5 DIMETHYL 1H PYRROL 2 YL)METHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; 6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; ANILINE DERIVATIVE; BCR ABL PROTEIN; CANERTINIB; CEP 2583; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ERLOTINIB; GEFITINIB; IMATINIB; ONCOPROTEIN; PELITINIB; PHTHALAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLO[2,3 D]PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; VANDETANIB; VASCULOTROPIN RECEPTOR; VATALANIB;

EID: 0034788453     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.1022     Document Type: Conference Paper
Times cited : (313)

References (53)
  • 6
    • 0031277578 scopus 로고    scopus 로고
    • Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and src family tyrosine kinases
    • (1997) Pharmacol Ther , vol.76 , pp. 55-71
    • Showalter, H.D.1    Kraker, A.J.2
  • 8
    • 0031957879 scopus 로고    scopus 로고
    • Current progress towards the development of tyrosine kinase inhibitors as anticancer agents
    • (1998) Emerging Drugs , vol.3 , pp. 279-292
    • Bridges, A.J.1
  • 9
    • 0032830412 scopus 로고    scopus 로고
    • The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases
    • (1999) Curr Med Chem , vol.6 , pp. 825-843
    • Bridges, A.J.1
  • 34
    • 0030561092 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor in blood vessel formation
    • (1996) TIBC , vol.6 , pp. 454-456
    • Breier, G.1    Risau, W.2
  • 35
    • 0003269592 scopus 로고    scopus 로고
    • Prospects for anti-angiogenic therapies based upon VEGF inhibition. New prospects in anticancer agents for the 21st century
    • in press
    • (2001) ACS book
    • Furet, P.1    Manley, P.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.